Pharmaceutical innovation is a key driver of improvements in health outcomes, quality of life and productivity for people with acute and chronic conditions. Pharmaceutical innovation is a key driver ...

Drug shortages are a growing global concern, affecting multiple therapeutic areas. Shortages are often concentrated in generic and biosimilar markets as a result of very low prices. We developed a ...

Dr Chris Henshall is an Honorary Professor at HERG. Chris has held various academic and senior management positions within the health research system and the higher education system within the UK.

In our Around the World in HTAs insight series we shed light on HTA successes and challenges around the world. In this edition, Sarin KC, Manit Sittimart, Chittawan Poonsiri, Yi Wang, and Simon ...

In this article, we discuss the global issue of drug shortages. We summarise our research where we developed a framework for quantifying the cost of a shortage, and through three case studies provide ...

Ellie is on the fellowship programme with City University, studying Economic Evaluation in Healthcare. She has a BSc in Biochemistry from the University of Bath and worked in the pharmaceutical ...

Charlotte is a communications and external affairs expert with over a decade of experience in global non-profits and academia with a specialist focus on health and development. Working with partners ...

Amanda is a health economist with expertise in economic evaluation and reimbursement, real-world evidence, and analysis of critical health policy issues. She is team leader for OHE’s Economics of ...

Donna is Professor of Health Economics at the School of Health and Related Research at the University of Sheffield.

This OHE webinar featured interviews with three global panellists representing government, healthcare, and academia to identify the most pressing challenges and gaps in our understanding. OHE ...

Eleanor is an economist specialising in the modelling and evaluation of healthcare interventions for infectious diseases.She works at the UK Health Security Agency, where she leads the agency’s ...

Matthew is an economist by training and after completing an MSc in Health Economics and Health Policy with a distinction from the University of Birmingham in 2022, he joined the OHE. He is supporting ...